Efficacy and tolerability of pegloticase for the treatment of chronic gout
in patients refractory to conventional treatment: two randomized controlled trials.
Increasing the percentage of patients who reach target serum uric acid levels is one of the greatest unmet needs in chronic gout
Crealta is committed to providing outstanding support and service to healthcare professionals and the patients that they serve with refractory chronic gout
The Pharmacor report entitled Gout forecasts that the chronic gout
segment of the gout market will double from $500 million in 2011 to more than $1 billion in 2021 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Progressive reduction in tophus burden wtih pegloticase therapy in patients with chronic gout
refractory to conventional therapy.
Allopurinol, a xanthine oxidase inhibitor drug, is prescribed for the treatment of chronic gout
and is used to prevent rather than treat gout attacks - indeed it can make acute attacks worse if given at the wrong time.
leads to long-term crystal deposition, usually in cooler body sites around joints and cartilage; the accumulation of these crystals results in pathognomonic tophi, or chalky deposits.
His overweight condition was worsened by a love of fine wines which caused chronic gout
and endless pain.
East Brunswick NJ) won approval for its drug for treating adult patients with a type of chronic gout
that doesn't respond well to conventional therapy.
A 50-year-old hypertensive Indian man, known to have had chronic gout
for the past 19 years, presented with clinically large, hard, nodular masses around the knees with limitation in the range of movement.